Sapient Capital »

Vertex Pharmaceuticals Incorporated shares owned by Sapient Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Sapient Capital from 13F filings

Historical chart of Sapient Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Sapient Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Sapient Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $15M 35k 418.01
2023-12-31 $14M 35k 406.89

More positions owned by Sapient Capital

Eli Lilly & Co. (LLY)
Applovin Corp Com Cl A (APP)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
UnitedHealth (UNH)
Costco Wholesale Corporation (COST)
Vistra Energy (VST)
Novo-nordisk A S Adr (NVO)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Merck & Co (MRK)
Netflix (NFLX)

View all positions for Sapient Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated